{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:04:28Z","timestamp":1777367068615,"version":"3.51.4"},"reference-count":8,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective.<\/jats:bold>\n                    Aldosterone synthase deficiency (ASD) is a rare, autosomal recessive inherited disease with an overall clinical phenotype of failure to thrive, vomiting, severe dehydration, hyperkalemia, and hyponatremia. Mutations in the CYP11B2 gene encoding aldosterone synthase are responsible for the occurrence of ASD. Defects in CYP11B2 gene have only been reported in a limited number of cases worldwide. Due to this potential life-threatening risk, comprehensive hormonal investigation followed by genetic confirmation is essential for the clinical management of offsprings.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Case presentation.<\/jats:bold>\n                    We herein describe an unusual case of ASD type II in a neonate with faltering growth as a single presenting symptom. To our knowledge, this is the first Greek case of ASD type II reported with confirmed genetic analysis. Next generation sequencing of her DNA revealed the homozygous mutation p.T185I (ACC-ATC) (c.554C&gt;T) (g.7757C&gt;T) in exon 3 of the CYP11B2 gene in the neonate, inherited from both parents who were heterozygotes for the mutation.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions.<\/jats:bold>\n                    Physicians handling neonates with faltering growth, particularly in the initial six weeks of life, should be suspicious of mineralocorticoid insufficiency either as isolated hypoaldosteronism or in the context of congenital adrenal hyperplasia. Essential investigations should be performed and appropriate treatment should be administered promptly without awaiting for the hormonal profile results. Interpretation of the clinical picture and the hormonal profile will guide the analysis of candidate genes. Primary selective hypoaldosteronism is a rare, life threatening disease, but still with an unknown overall population impact. Thus, reporting cases with confirmed gene mutations is of major importance.\n                  <\/jats:p>","DOI":"10.2478\/enr-2020-0025","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T10:46:19Z","timestamp":1598611579000},"page":"227-229","source":"Crossref","is-referenced-by-count":4,"title":["Aldosterone synthase deficiency type II: an unusual presentation of the first Greek case reported with confirmed genetic analysis"],"prefix":"10.2478","volume":"54","author":[{"given":"Stayroula","family":"Papailiou","sequence":"first","affiliation":[{"name":"Second Department of Paediatrics , Children\u2019s Hospital \u2018P. & A. Kyriakou, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elpis Athina","family":"Vlachopapadopoulou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Growth and Development , \u2018P. & A. Kyriakou Children\u2019s Hospital , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Sertedaki","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics , National and Kapodistrian University of Athens Medical School, \u2018Aghia Sophia\u2019 Children\u2019s Hospital , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despoina","family":"Maritsi","sequence":"additional","affiliation":[{"name":"Second Department of Paediatrics , Children\u2019s Hospital \u2018P. & A. Kyriakou, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Syggelos","sequence":"additional","affiliation":[{"name":"Second Department of Paediatrics , Children\u2019s Hospital \u2018P. & A. Kyriakou, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki","family":"Syggelou","sequence":"additional","affiliation":[{"name":"Second Department of Paediatrics , Children\u2019s Hospital \u2018P. & A. Kyriakou, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"2026042723212996277_j_enr-2020-0025_ref_001_w2aab3b7c15b1b6b1ab1ab1Aa","doi-asserted-by":"crossref","unstructured":"Bizzarri C, Olivini N, Pedicelli S, Marini R, Giannone G, Cambiaso P, Cappa M. Congenital primary adrenal insufficiency and selective aldosterone defects presenting as salt-wasting in infancy: a single center 10-year experience. Ital J Pediatr 42, 73, 2016.10.1186\/s13052-016-0282-3","DOI":"10.1186\/s13052-016-0282-3"},{"key":"2026042723212996277_j_enr-2020-0025_ref_002_w2aab3b7c15b1b6b1ab1ab2Aa","doi-asserted-by":"crossref","unstructured":"Hattangady NG, Olala LO, Bollag WB, Rainey WE. Acute and chronic regulation of aldosterone production. Mol Cell Endocrinol 350, 151\u2013162, 2012.10.1016\/j.mce.2011.07.034","DOI":"10.1016\/j.mce.2011.07.034"},{"key":"2026042723212996277_j_enr-2020-0025_ref_003_w2aab3b7c15b1b6b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"Jessen CL, Christensen JH, Birkebaek NH, Rittig S. Homozygosity for a mutation in the CYP11B2 gene in an infant with congenital corticosterone methyloxidase deficiency type II. Acta P\u00e6diatrica 101, e519\u2013e525, 2012.10.1111\/j.1651-2227.2012.02823.x","DOI":"10.1111\/j.1651-2227.2012.02823.x"},{"key":"2026042723212996277_j_enr-2020-0025_ref_004_w2aab3b7c15b1b6b1ab1ab4Aa","doi-asserted-by":"crossref","unstructured":"Kayes-Wandover Tannin GM, Shulman D, Peled D, Jones KL, Karaviti L, White PC. Congenital hyperreninemic hypoaldosteronism unlinked to the aldosterone synthase (CYP11B2) gene. J Clin Endocrinol Metab 86, 5379\u20135382, 2001.10.1210\/jcem.86.11.8005","DOI":"10.1210\/jcem.86.11.8005"},{"key":"2026042723212996277_j_enr-2020-0025_ref_005_w2aab3b7c15b1b6b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"Klomchan T, Supornsilchai V, Wacharasindhu S, Shotelersuk V, Sahakitrungruang T. Novel CYP11B2 mutation causing aldosterone synthase (P450c11AS) deficiency. Eur J Pediatr 171, 1559\u20131562, 2012.10.1007\/s00431-012-1792-7","DOI":"10.1007\/s00431-012-1792-7"},{"key":"2026042723212996277_j_enr-2020-0025_ref_006_w2aab3b7c15b1b6b1ab1ab6Aa","doi-asserted-by":"crossref","unstructured":"Miaoa H, Yub Z, Lua L, Zhua H, Auchusc RJ, Liuc J, Jiangd J, Pana H, Gonga F, Chena S, Lua Z. Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review. Steroids 150, 108448, 2019.10.1016\/j.steroids.2019.108448","DOI":"10.1016\/j.steroids.2019.108448"},{"key":"2026042723212996277_j_enr-2020-0025_ref_007_w2aab3b7c15b1b6b1ab1ab7Aa","doi-asserted-by":"crossref","unstructured":"Storey C, Dauger S, Deschenes G, Heneau A, Baud O, Carel JC, Martinerie L. Hyponatremia in children under 100 days old: incidence and etiologies. Eur J Pediatr 178, 1353\u20131361, 2019.10.1007\/s00431-019-03406-8","DOI":"10.1007\/s00431-019-03406-8"},{"key":"2026042723212996277_j_enr-2020-0025_ref_008_w2aab3b7c15b1b6b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"Turan I, \u039aotana D, Tastana M, Gurbuza F, Topaloglua AK, Yuksela B. Molecular genetic studies in a case series of isolated hypoaldosteronism due to biosynthesis defects or aldosterone resistance. Clin Endocrinol (Oxf) 88, 799\u2013805, 2018.10.1111\/cen.13603","DOI":"10.1111\/cen.13603"}],"container-title":["Endocrine Regulations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/enr\/54\/3\/article-p227.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/enr-2020-0025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:06:53Z","timestamp":1777363613000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/enr-2020-0025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":8,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,8,27]]},"published-print":{"date-parts":[[2020,7,1]]}},"alternative-id":["10.2478\/enr-2020-0025"],"URL":"https:\/\/doi.org\/10.2478\/enr-2020-0025","relation":{},"ISSN":["1336-0329"],"issn-type":[{"value":"1336-0329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]}}}